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Abstract 
We have previously established that the eleven cytosolic peptides phosphorylated in response to acute glucagon challenge in isolated 
rat hepatocytes undergo rapid dephosphorylation f llowing transfer to medium free of 32po3-. This dephosphorylation, far from being a 
simple process, is complex and asynchronous. This novel finding of asynchrony raises the question of whether, by analogy to glucagon, 
protein dephosphorylation is asynchronous during the recovery phase from acute challenge with noradrenaline, vasopressin orangiotensin 
II. One-dimensional SDS-PAGE of hepatocyte extracts indicates that noradrenaline stimulates the phosphorylation f ten cytosolic 
peptides, whereas vasopressin and angiotensin II stimulate the phosphorylation f six cytosolic peptides. Transfer of the hormone-chal- 
lenged hepatocytes to medium devoid of 32po43- and hormone led to the rapid net dephosphorylation of the 32p-labelled phospho- 
peptides, albeit at different rates. In all instances, the most rapidly dephosphorylated phosphopeptide was glycogen phosphorylase. 
Statistical nalysis indicates that during recovery from noradrenaline challenge three distinct groups of phosphopeptides can be delineated 
on the basis of their rates of dephosphorylation. Despite the fact that vasopressin and angiotensin II stimulate the phosphorylation f the 
same sub-set of phosphopeptides, there were differences in the rates of dephosphorylation of these phosphopeptides uring the recovery 
phase from acute hormonal challenge. 
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1. Introduction 
Many hormones modulate biological processes by stim- 
ulating the phosphorylation of regulatory proteins. The 
direction of hepatic metabolism is determined to a signifi- 
cant extent by the phosphorylation status of regulatory 
enzymes, including glycogen synthase, glycogen phospho- 
rylase, glycogen phosphorylase kinase, the bifunctional 
enzyme fructose 6-phosphate 2-kinase/fructose 2,6-bis- 
phosphatase (hereafter referred to as fructose 6-phosphate 
2-kinase), pyruvate kinase and phenylalanine hydroxylase 
[1]. Although there have been a number of studies using 
one- and two-dimensional e ectrophoresis of the proteins 
that are phosphorylated in isolated hepatocytes in response 
to challenge with glucagon and other hormones, including 
noradrenaline, vasopressin and angiotensin II [2-1 1], there 
is surprisingly little information on the dephosphorylation 
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of these phosphopeptides during the recovery phase from 
acute hormonal challenge. 
We have established that, in agreement with earlier 
studies, glucagon stimulates the phosphorylation of the 
eleven cytosolic peptides in isolated hepatocytes equili- 
brated in medium containing 32po43- [1 1]. The transfer of 
these hepatocytes to fresh medium free of 32po43- and 
hormone initiates the dephosphorylation f the phospho- 
peptides in an asynchronous manner. Statistical analysis of 
the rates of dephosphorylation allowed us to identify four 
distinct groups of phosphopeptides, comprising in descend- 
ing order of rates of dephosphorylation (1) glycogen phos- 
phorylase, (2) fructose 6-phosphate 2-kinase, pyruvate ki- 
nase and the a-subunit of glycogen phosphorylase kinase, 
(3) the fl-subunit of glycogen phosphorylase kinase, fruc- 
tose 1,6-bisphosphatase, two unidentified 48- and 46-kDa 
phosphopeptides and ribosomal protein $6, and (4) glyco- 
gen synthase and phenylalanine hydroxylase. This novel 
finding of asynchrony implies that the process of protein 
dephosphorylation n intact cells may be complex and be a 
potential site for endocrine and nutritional modulation and 
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raises the question of whether protein dephosphorylation s 
asynchronous during the recovery phase from acute chal- 
lenge with noradrenaline, vasopressin or angiotensin II.
2. Materials and methods, 
2.1. Chemicals 
Carrier-free [32p]orthophosphate (9 mCi/mmol) was 
obtained from Bresatec, Adelaide, South Australia. 
Glucagon was purchased from CSL-NOVO Pty., N.S.W. 
(Australia) and collagenase (type IV) from the Sigma 
Chemicals, St. Louis, USA. Standards for SDS-polyacryl- 
amide gel electrophoresis (SDS-PAGE) were from Bio-Rad 
Laboratories Pty., N.S.W (Australia). The HPLC Analyti- 
cal Column was purchased from Alltech Associates Aus- 
tralia Pty., Baulkham Hills, N.S.W. (Australia). All other 
chemicals were ANALAR or equivalent grade. 
2.2. Hepatocyte isolation, glucagon challenge and the 
isolation of the 32 p-labelh,d cytosolic protein fraction 
Hepatocytes were isolated from fed male Wistar rats as 
described by Aggarwal and Palmer [11] and resuspended 
in 20-30 ml Krebs-Ringer bicarbonate buffer [12] equili- 
brated in 5% CO 2, 95% 0 2 to a final concentration of 
20-25 mg protein/ml. Cell viability assessed by exclusion 
of Trypan blue ranged between 85 and 95%. The hepato- 
cytes (2-4 × 106 cells/n01) were labelled with approx. 0.5 
mCi 32PO43- and incubated in a low-phosphate (0.1 mM) 
Krebs-Ringer bicarbonate buffer containing 16 mM L- 
lactate and 4 mM pyruvate as described by Garrison and 
Wagner [4]. The cells were gassed continuously with 5% 
CO 2, 95% 0 2 and incubated at 37°C in a shaking water- 
bath for 45 min to equilibrate the intracellular phosphate 
pools with 32po3- [11]. Some cell samples were then 
exposed for 5 min to noradrenaline (10 /zM), vasopressin 
(10 mUnits/ml) or angiotensin (10 nM), whereas others 
(controls) were not treated with hormone. For comparison, 
certain cells were treated with glucagon (10 nM) as de- 
scribed in [11]. Hormone concentrations were based on 
those used in other studies [4,11]. At this junction, cells 
were either diluted in digitonin fractionation buffer for 6-8 
s to release cytosolic proteins or centrifuged by the proce- 
dure of Le Cam [5] and the hepatocytes resuspended in
fresh low-phosphate Krebs-Ringer bicarbonate buffer free 
of 32 po  3-  and hormone. These latter cells were further 
incubated at 37°C in a shaking waterbath with continuous 
gassing with 5% CO 2, 95% O z for 30 min. At time 
intervals, samples of the incubation media were taken and 
diluted (5-fold) in digitonin fractionation buffer [11] for 
6-8 s to release cytosolic proteins. Brief (< 8 s) exposure 
of cells to digitonin buffer serves to lyse the cell mem- 
brane and ensure 90-95'70 release of the cytosolic proteins 
with minimal contamination from mitochondrial, endoplas- 
mic reticular, or nuclear proteins [13]. The remaining cell 
structures were removed by centrifugation at 13000× g 
for 10-15 s. The supernatant was boiled immediately for 5 
min in SDS buffer and stored frozen at -20°C. Prior to 
electrophoretic analysis, this cytosolic fraction was thawed 
and dialysed against 2- to 3-times changes of 10 volumes 
of dialysis buffer [11] at 4°C for up to 10 h to remove 
32po3- and other 32p-labelled low molecular mass 
metabolites. 
2.3. One-dimensional gel electrophoresis 
The cytosolic proteins were resolved mainly by one-di- 
mensional SDS-PAGE by a modification of the method of 
Laemmli [14] as described by Aggarwal and Palmer [11]. 
The gels were stained for 20 min at 60°C with 0.25% 
(w/v)  Coomassie blue solution in 50% (w/v) trichloro- 
acetic acid and destained in 7% (v/v)  acetic acid, and 
thereafter vacuum-dried in a gel drier for 2 h on filter 
paper. Dried gels were exposed to Kodak X-Omat film at 
-80°C for 2-4 days and the resultant autoradiographs 
were scanned using an Epson Color Image Scanner GT- 
4000. Protein was determined by the method of Lowry et 
al. [15]. The molecular masses of individual phospho- 
peptides were determined using SDS-PAGE molecular 
mass (14.4-200 kDa) marker proteins. The values shown 
are the means for at least four separate xperiments. 
In certain instances, the cytosolic protein fraction after 
dialysis was boiled in SDS buffer and resolved by two-di- 
mensional electrophoresis by the method of O'Farrell [16] 
as described by Aggarwal and Palmer [11]. 
2.4. Determination of the specific radioactivity of the 
[32p]ATP pool 
The specific radioactivity of the [32p]ATP pool in 
isolated hepatocytes was determined by the method of 
Aggarwal and Palmer [11] by HPLC using an Econosil 
C-18, 10/z Analytical Anion Exchange Column. ATP was 
estimated by its absorbance at 254 nm relative to known 
concentrations of ATP, whereas the radioactivity associ- 
ated with the ATP peak was determined by scintillation 
counting of the relevant fraction(s) of the column eluate. In 
agreement with Garrison [2], the specific radioactivity of 
the [32 P]ATP pool was in steady-state after 45 min incuba- 
tion in medium containing 32 PO43- and not changed by the 
addition of hormone (results not shown). 
2.5. Calculation and expression of results 
Rates of net dephosphorylation of the different 
phosphopeptides were determined for at least four experi- 
ments and are expressed as means + S.E. The statistical 
significance of differences between groups of data was 
determined by ANOVA. 
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3. Results 
3.1. Identity of the hepatic peptides phosphorylated in
response to acute challenge with noradrenaline, vaso- 
pressin or angiotensin 
We have previously established that glucagon stimu- 
lates the phosphorylation f eleven cytosolic peptides in 
isolated hepatocytes [11]. Nine of these peptides were 
tentatively identified by one- and two-dimensional SDS- 
PAGE as the ce- and fl-subunits of glycogen phospho- 
rylase kinase, glycogen phosphorylase, glycogen synthase, 
pyruvate kinase, fructose 6-phosphate 2-kinase, phenyl- 
alanine hydroxylase, fructose 1,6-bisphosphatase nd ribo- 
somal protein $6. Two phosphopeptides do not correspond 
in molecular mass (48 kDa and 46 kDa) to any known 
phosphopeptide. These phosphopeptides have been re- 
ported by others [4,8,9,11]. Whereas two-dimensional 
SDS-PAGE failed to detect the 48 kDa phosphopeptide 
(see Ref. [11]), it resolved the 46-kDa phosphopeptide into 
multiple components (Fig. 1), the 32p-labelling of which 
increased in parallel in response to hormonal challenge. 
Others [4,16] have proposed that these multiple compo- 
nents are the result of carbamylation during sample prepa- 
ration. An important question is to what extent other 
hormones, particularly noradrenaline, vasopressin and an- 
giotensin II, stimulate the phosphorylation of the same 
family of cytosolic phosphopeptides as glucagon. 
One-dimensional SDS-PAGE of dialysed extracts indi- 
cated that of the approximately 30 cytosolic peptides that 
become 32p-labelled following equilibration of the cells 
32 Pt') 3 - with iv  4 , ten were phosphorylated in response to acute 
challenge with noradrenaline (Table 1). On the basis of 
molecular mass and other studies [2,4,8,11], including 
two-dimensional SDS-PAGE, these peptides are identified 
as glycogen phosphorylase (93 kDa), glycogen synthase 
(85 kDa), fructose 6-phosphate 1-kinase (77 kDa), pyru- 
Fig. 1. Two-dimensional SDS-PAGE of the as yet unidentified 46 kDa 
phosphopeptide (A) before and (B) after challenge with glucagon (10 
nM). The peptide resolves into components with multiple isoelectric 
points (4.5-5.1). 
vate kinase (61 kDa), fructose 6-phosphate 2-kinase (55 
kDa), phenylalanine hydroxylase (52 kDa), fructose 1,6- 
bisphosphatase (42 kDa) and ribosomal protein $6 (34 
kDa). Like glucagon, noradrenaline stimulated the 
phosphorylation f two peptides that do not correspond in 
molecular mass (48 kDa and 46 kDa) to any identified 
phosphopeptide. The profile of cytosolic peptides phospho- 
rylated in response to noradrenaline is similar, but not 
identical, to that associated with glucagon-stimulated phos- 
Table 1 
Cytosolic peptides whose phosphorylation is stimulated in isolated hepatocytes by glucagon, noradrenaline, vasopressin and angiotensin II 
Phosphopeptide Glucagon Noradrenaline Vasopressin Angiotensin II 
(10 nM) (10/xM) (10 munits/ml) (10 nM) 
Phosphorylase kinase ot-subunit 2.9 ± 0.1 ns ns ns 
Phosphorylase kinase/3-subunit 3.5 ± 0.1 ns ns ns 
Glycogen phosphorylase 4.0 5:0.1 2.7 ± 0.1 3.4 ± 0.2 2.7 ± 0.1 
Glycogen synthase 3.9 ± 0.1 2.6 ± 0.1 ns ns 
Fructose 6-phosphate 1-kinase ns 1.6 ± 0.2 ns ns 
72 kDa ns ns 4.2 ± 0.2 4.1 ± 0.1 
Pyruvate kinase 4.2 ± 0.1 3.3 ± 0.2 3.2 5:0.2 3.6 ± 0.1 
Fructose 6-phosphate 2-kinase 3.9 ± 0.1 1.8 + 0.1 ns ns 
Phenylalanine hydroxylase 6.0 ± 0.1 3.4 ± 0.2 2.3 ± 0.1 2.2 5:0.2 
48 kDa 10.2 + 0.1 1.3 5:0.1 ns ns 
46kDa 4.3±0.1 1.6 ± 0.1 1.6-t-0.1 1.45:0.1 
Fructose 1,6-bisphosphatase 2.6 ± 0.1 1.4 5:0.1 ns ns 
Ribosomal protein $6 1.9 ± 0.1 1.4 ± 0.1 2.7 ± 0.1 2.2 5:0.2 
Values are shown (means ± S.E. for four experiments) for increases (n-fold) above basal (no hormone) in the phosphorylation of the different 
phosphopeptides. All increases were statistically significant (at least P < 0.05). ns, not phosphorylated in response to hormonal challenge. 
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phorylation, the difference.s being that glucagon exclu- 
sively stimulates the phosphorylation f the a- and r-sub- 
units of glycogen phosphorylase kinase, whereas nor- 
adrenaline xclusively stimulates the phosphorylation of
fructose 6-phosphate 1-kinase (Table 1). 
In contrast to noradrenaline, one-dimensional SDS- 
PAGE of dialysed extracts indicated that vasopressin and 
angiotensin II stimulate the phosphorylation f six cytoso- 
lic peptides (Table 1). Tile number and sizes of these 
32 P-labelled phosphopeptides r olved by SDS-PAGE were 
highly reproducible. On the basis of the molecular mass of 
the individual phosphopeptides and by comparison with 
other studies [4,8], five of these phosphopeptides are iden- 
tified as glycogen phosphorylase (93 kDa), pyruvate kinase 
(61 kDa), phenylalanine hydroxylase (52 kDa) and riboso- 
mal protein $6 (34 kDa). Previous studies [11 ] have con- 
firmed the identifies of these phosphopeptides using two- 
dimensional SDS-PAGE, although two cytosolic phospho- 
peptides with molecular masses of 72 kDa and 46 kDa 
remain unidentified. It is important to note that the un- 
known 72 kDa phosphopepfide is not a substrate for either 
glucagon-stimulated or noradrenaline-stimulated phospho- 
rylation (Table 1). 
3.2. Fate of hepatic phosphopeptides during recovery from 
acute hormonal challenge 
Although the hormone--stimulated phosphorylation of
cytosolic peptides in isolated hepatocytes has been exten- 
sively studied, particularly in response to glucagon, there 
is surprisingly little quantitative information on the 
dephosphorylation of these phosphopeptides. We have pre- 
viously established [11] that the dephosphorylation of the 
eleven glucagon-stimulated cytosolic phosphopeptides is 
asynchronous during the recovery phase from acute 
glucagon challenge (Table; 2). These findings pose the 
question of whether the dephosphorylation f the hor- 
mone-stimulated phosphopeptides is asynchronous during 
recovery from acute challenge with noradrenaline, vaso- 
pressin and angiotensin II.
To address this problem, hepatocytes pre-equilibrated 
with 32 po 3- were challenged with hormone and thereafter 
transferred to fresh low-phosphate Krebs-Ringer bicarbon- 
ate medium free of both glucagon and 32po3- by the 
procedure of Le Cam [5]. Transfer of hepatocytes to 
medium devoid of 32 PO43_ led to a rapid decline in the 
radioactivity associated with the [32 P]ATP pool, the rate of 
decline in the specific radioactivity of the [32 P]ATP being 
6.7% per min (results not shown: see Ref. [11] for details). 
Autoradiographic analysis of SDS-PAGE of the cytosolic 
polypeptides at time intervals after transfer indicated that 
the transfer procedure promotes the rapid net dephospho- 
rylation of the 32 P-labelled phosphopepfides, albeit at dif- 
ferent rates (Figs. 2-4, Table 2). 
In all instances, the most rapidly dephosphorylated 
phosphopeptide was glycogen phosphorylase (Table 2). 
The rate of its dephosphorylation, however, was signifi- 
cantly slower (by almost 2-fold, P < 0.001) during recov- 
ery from challenge with noradrenaline, vasopressin and 
angiotensin II than from challenge with glucagon (Table 
2). Statistical analysis indicates that during recovery from 
noradrenaline challenge, a group of phosphopeptides is 
dephosphorylated at a rate slower than glycogen phospho- 
rylase (P < 0.001). This group comprises glycogen syn- 
thase, pyruvate kinase, fr ~ctose 6-phosphate 2-kinase, fruc- 
tose 1,6-bisphosphatase, phenylalanine hydroxylase and 
the unknown 48- and 46-kDa phosphopepfides. In fact, 
within this group, the rates of dephosphorylafion of the 48- 
and 46-kDa phosphopeptides are less than those of the 
other phosphopeptides (P < 0.05), except phenylalanine 
hydroxylase. Ribosomal protein $6 was dephosphorylated 
at a rate significantly slower (P < 0.05) than the other 
Table 2 
Rates of  dephosphorylat ion f  cytosolic phosphopeptides during the recovery phase from acute 
angiotensin II 
challenge with glucagon, noradrenaline, vasopressin or 
Phosphopeptide Glucagon Vasopressin Angiotensin II Noradrenaline 
(10 nM) (10 muni ts /ml )  (10 nM) (10 /zM)  
Glycogen phosphorylase 14.2 + 1.6 7.5 + 0.5 * * * 7.3 ± 0.4 * * " 7.8 ± 0.3 * * * 
Fructose 6-phosphate 2-kinase 8.3 _+ 0.7 ns ns 5.0 ± 0.3 * * * 
Pyruvate kinase 6.8 ± 0.7 5.3 ± 0.5 4.0 + 0.1 * * 5.4 _+ 0.3 * 
Phosphorylase kinase a-subunit  6.2 ± 0.6 ns ns ns 
Phosphorylase kinase/3-subunit  5.2 ± 0.1 ns ns ns 
Fructose 1,6-bisphosphatase 4.9 ± 0.4 ns ns 5.0 ± 0.2 
48 kDa 4.6 ± 0.1 ns ns 3.9 + 0.3 
46 kDa 4.4 _+ 0.2 6.3 ± 0.3 3.1 ± 0.4 * * * 3.9 _+ 0.2 
Ribosomal protein $6 4.2 ± 0.1 6.2 ± 0.4 * 3.8 ± 0.3 * * * 3.2 ± 0. l  
Glycogen synthase 2.4 ± 0.2 ns ns 5.5 ± 0.1 * 
Phenylalanine hydroxylase 2.3 ± 0.2 4.2 ± 0.2 * 3.1 ± 0.1 4.5 ± 0.3 * 
72 kDa ns 6.2 ± 0.6 5.1 ± 0.1 ns 
Fructose 6-phosphate l-kinase ns ns ns 4.4 ± 0.5 
Values are means + S.E. for four experiments. Statistically significant differences between rates fol lowing glucagon challenge compared to fol lowing 
challenge with the other hormones is denoted by ' P < 0.05; * * P < 0.01; * * * P < 0.001. ns, not phosphorylated in response to hormonal challenge. 
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Fig. 2. The time course of net dephosphorylation f the individual 
cytosolic phosphopeptides during the recovery phase from acute nor- 
adrenaline challenge. Hepatocytes pre-equilibrated with 32po3- and 
treated with noradrenaline (10 ixM) were transferred to fresh low-phos- 
phate Krebs-Ringer bicarbonate buffer free of 32po2- and glucagon. 
This transfer triggered the dephosphorylation f cytosolic phospho- 
peptides. Fig. A shows the dephosphorylation f the phosphopeptides 
identified (see text) as glycogen phosphorylase ([]), pyruvate kinase (©), 
phenylalanine hydroxylase (0) ,  the as yet unidentified 46-kDa phospho- 
peptide (zx) and ribosomal protein $6 (• ) ,  whereas Fig. B shows 
glycogen synthase ([]), fructose 6-phosphate 1-kinase (11), fructose 
6-phosphate 2-kinase (©), the as yet unidentified 48-kDa phosphopeptide 
(O) and fructose 1,6-bisphosphatase (zx). Values, expressed relative (%) 
to maximal phosphorylation (0 time), are the means + S.E. from at least 
four separate xperiments. 
noradrenaline-stimulated phosphopeptides (Table 2 and 
Fig. 2). 
Despite the fact that vasopressin and angiotensin II
stimulate the phosphorylation f the same sub-set of cy- 
tosolic peptides (Table 1), there were consistent differ- 
ences in the rates of dephosphorylation of these phospho- 
peptides during the recovery phase from acute hormonal 
challenge (Figs. 3 and 4, Table 2). One common feature is 
that glycogen phosphorylase and pbenylalanine hydroxyl- 
ase were the most rapidly dephosphorylated and the most 
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Fig. 3. The time course of net dephosphorylation f the individual 
cytosolic phosphopeptides during the recovery phase from acute vaso- 
pressin challenge. Hepatocytes pre-equilibrated with 32 PO~- and treated 
with vasopressin (10 mUnits/ml) were transferred to fresh low-phosphate 
Krebs-Ringer bicarbonate buffer free of 3Zpo~- and glucagon. This 
transfer triggered the dephosphorylation f cytosolic phosphopeptides. 
The figure shows the dephosphorylation of the phosphopeptides identified 
(see text) as glycogen phosphorylase ([2), pyruvate kinase (O), phenyl- 
alanine hydroxylase (0) ,  the as yet unidentified 72- (m) and 46-kDa 
(zx) phosphopeptides and ribosomal protein $6 (• ) .  Values, expressed 
relative (%) to maximal phosphorylation (0 time), are the means + S.E. 
from at least four separate xperiments. 
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Fig. 4. The time course of net dephosphorylation f the individual 
cytosolic phosphopeptides during the recovery phase from acute an- 
giotensin 11 challenge. Hepatocytes pre-equilibrated with 32po3- and 
treated with angiotensin II (10 nM) were transferrred to fresh low-phos- 
phate Krebs-Ringer bicarbonate buffer free of 32 po43- and glucagon. 
This transfer triggered the dephosphorylation f cytosolic phospho- 
peptides. The figure shows the dephosphorylation of the phosphopeptides 
identified (see tex0 as glycogen phosphorylase ([]), pyruvate kinase ((3), 
phenylalanine hydroxylase (0) ,  the as yet unidentified 72- (11) and 
46-kDa phosphopeptide (A) and ribosomal protein S6 (A). Values, 
expressed relative (%) to maximal phosphorylation (0 time), are the 
means + S.E. from at least four separate xperiments. 
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slowly dephosphorylated phosphopeptides, respectively. 
The rates of dephosphory]iation f the other phospho- 
peptides, however, were consistently higher (P < 0.05 at 
least) during recovery from vasopressin as opposed to 
angiotensin II. There were also differences between an- 
giotensin II and vasopress!in in the temporal pattern of 
dephosphorylation f the phosphopeptides. During recov- 
ery from angiotensin II challenge, the unknown 72-kDa 
phosphopeptide, pyruvate kiinase and ribosomal protein $6 
were dephosphorylated at a rate significantly slower (P < 
0.01) than glycogen phosphorylase but faster (P  < 0.05) 
than phenylalanine hydroxylase and the unknown 46-kDa 
phosphopeptide, which were dephosphorylated at identical 
rates (Table 2 and Fig. 4). By contrast, during recovery 
from vasopressin challenge, the unknown 46- and 72-kDa 
phosphopeptides, pyruvate kinase and ribosomal protein 
$6 were dephosphorylated at a rate significantly slower 
(P < 0.01) than glycogen phosphorylase but faster (P < 
0.05) than phenylalanine hydroxylase (Table 2 and Fig. 3). 
4.  D iscuss ion  
4.1. Identity of the hormone-stimulated h patic phospho- 
peptides 
Glucagon, noradrenaline, angiotensin II and vasopressin 
affect protein phosphorylation via different signalling path- 
Glueagon 
Ii ATP /ee 
i i I / 
I / 
I 
I 
I 
I 
I 
I 
I 
[Cill 
InsP 3 
Target ~roteins 
/ 
j J~  
cAMP 
t 
cAMP-PK ! / 
/ Protein 
/ /~/ / / /  ~ phosphatases 
Ca2+/Calmodulin-PK 
~ protein-(~) 
DAG ~ PK-C 
Fig. 5. Scheme illustrating the possible signalling mechanisms for glucagon, noradrenaline, vasopressin and angiotensin II. These hormones bind to their 
specific receptors (Rec) situated in the cell membrane and interact with associated G proteins (G~ and Gq). Glucagon activates G~, a process which leads to 
the activation of adenylate cyclase (AC) and consequently cAMP-dependent protein kinase (cAMP-PK). Noradrenaline, vasopressin and angiotensin II, by 
contrast, activate Gq and thereby phospholipase C (PLC#), the action of which generates the second messengers inositol tfisphosphate (InsP 3) and 
diacylglycerol (DAG). DAG fur:her leads to the activation of protein kinase C (PK-C), whereas InsP 3 increases Ca 2+ levels and thereby activates 
Ca 2+/calmodulin-dependent protein kinase (Ca 2 +/calmodulin-PK). There is cross-talk between the cAMP- and |nsP3/Ca 2 +-mediated pathways [ 17,18]: 
glucagon potentiates the action of CaE+-linked hormones by effects of G~ (via stimulation of a plasma membrane Ca 2+ channel) and cAMP on Ca 2+ 
levels, whereas there is feedback inhibition of adenylate cyclase by Ca 2+. These modulatory effects are shown as dashed lines, cAMP-dependent protein 
kinase, Ca2+/calmodulin-dependent protein kinase and PK-C phosphorylate different subsets of cytosolic peptides, a process opposed by the action of 
protein phosphatases. Despite the communality oftheir InsP 3 - and Ca2+-mediated signalling pathways, noradrenaline stimulates the phosphorylation f a 
different subset of peptides compared to vasopressin and angiotendin II.
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ways (Fig. 5), although there is evidence of cross-talk 
between these pathways [17,18]. Consequently, it is pre- 
dicted that the different hormones may stimulate the phos- 
phorylation of different subsets of cytosolic peptides. As in 
the case of the glucagon-stimulated phosphopeptides [11], 
the number and molecular masses of the phosphopeptides 
whose 32p-labelling was stimulated in response to nor- 
adrenaline, vasopressin and angiotensin II were highly 
reproducible and agree so closely with published studies as 
to permit us to identify with some measure of confidence 
at least some of the hormone-stimulated phosphopeptides. 
These are glycogen phosphorylase (93 kDa), glycogen 
synthase (85 kDa), fructose 6-phosphate 1-kinase (77 kDa), 
pyruvate kinase (61 kDa), fructose 6-phosphate 2-kinase 
(55 kDa), phenylalanine hydroxylase (52 kDa), fructose 
1,6-bisphosphatase (42kDa) and ribosomal protein $6 (34 
kDa). Three phosphopeptides with molecular masses of 
72-, 48-and 46-kDa remain unidentified, the 46-kDa 
phosphopeptide having multiple components possibly as 
the result of carbamylation during sample preparation 
[4,16]. The different hormones timulate the phosphoryla- 
tion of different subsets of cytosolic peptides. Noradrena- 
line, in agreement with earlier studies using one-dimen- 
sional electrophoresis [2], stimulates the phosphorylation 
of 10 cytosolic peptides, including glycogen phospho- 
rylase, glycogen synthase, fructose 6-phosphate 1-kinase, 
pyruvate kinase, fructose 6-phosphate 2-kinase, phenyl- 
alanine hydroxylase, fructose 1,6-bisphosphatase nd ribo- 
somal protein $6 as well as two as yet unidentified phos- 
phopeptides with molecular masses of 48 kDa and 46 kDa. 
This subset of peptides resembles that phosphorylated in 
response to glucagon, except hat the a- and fl-subunits of 
glycogen phosphorylase kinase are not substrates for nor- 
adrenaline-stimulated phosphorylation, whereas noradrena- 
line exclusively stimulates the phosphorylation f fructose 
6-phosphate 1-kinase (Table 1). 
In contrast to noradrenaline, vasopressin and an- 
giotensin II stimulate the phosphorylation f six peptides, 
including glycogen phosphorylase, pyruvate kinase, 
phenylalanine hydroxylase and ribosomal protein $6, as 
well as two as yet unidentified phosphopeptides with 
molecular masses of 72 kDa and 46 kDa, respectively. 
Some, but not all, of these peptides have been identified as 
substrates for vasopressin-and angiotensin-stimulated 
phosphorylation by other investigators [2,3]. 
The basis for the identification of the different cytosolic 
phosphopeptides has been dealt with in detail elsewhere 
[11]. Briefly, it is based on a combination of both one- and 
two-dimensional electrophoresis. Although one-dimen- 
sional electrophoresis resolves more phosphopeptides than 
two-dimensional electrophoresis, ncluding glycogen syn- 
thase (85 kDa), the a- and fl-subunits of glycogen phos- 
phorylase kinase (147 and 123 kDa, respectively) and the 
as yet unknown 48-kDa phosphopeptide, it does suffer 
A B C D 
Group 1 
Glycogen phosphorylase 
~1 p<0.001 
Group 2 
Glycogen synthase 
Pyrovate kinase 
Fructose 6-pbosphate 2-kinase 
Fructose 1,6-bisphosphatase 
Phenylalanine hydroxylase 
48 kDa protein 
46 kDa protein 
I p<0.05 
Group 3 
Ribosomal protein $6 
Group 1 
Glycogen phosphorylase 
I p<0.05 
Group 2 
46 kDa protein 
Ribosomal protein $6 
72 kDa protein 
Pyruvate kinase 
p<0.05 
Group 3 
Phenylalanine hydroxylase 
Group 1 
Glycogen phosphorylase 
I p<0.01 
Group2 
72 kDa protein 
Pyruvate kinase 
Ribosomal protein $6 
I p<0.05 
Group 3 
Phenylalanine hydroxylase 
46 kDa protein 
Group 1 
Glycogen phosphorylase 
I p<O.001 
Group 2 
Fructose 6-phosphate 2-kinase 
Pyruvate kinase 
Phosphorylase kinase alpha-subunit 
I p<O.001 
Group 3 
Phosphorylase kinase 6-subunit 
Fructose 1,6-bisphosphatase 
48 kDa protein 
46 kDa protein 
Ribosomal protein $6 
I p<0.0Ol 
Group 4 
Glycogen synthase 
Phenylalanine hydroxylase 
Fig. 6. The proposed sequence of dephosphorylation reactions of the individual hepatic ytosolic phosphopeptides uring recovery from acute challenge 
with (A) noradrenaline, (B) vasopressin a d (C) angiotensin II. For comparative purposes, the proposed sequence ofdephosphorylation reactions during 
recovery from glucagon (D). Post-glucagon net protein dephosphorylation is asynchronous. Based on statistical nalysis of differences between the rates of 
net dephosphorylation of the 11 glucagon-stimulated cytosolic phosphopeptides, four groups of phosphopeptides are delineated (P < 0.001). This scheme 
proposes that hese four groups constitute a sequence ofdephosphorylation events. 
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from the obvious disadvantage that it is unable to resolve 
mixtures of multiple phosphopeptides with different iso- 
electric points. Indeed, two-dimensional e ectrophoretic 
studies established that certain of the phosphopeptides (the 
93-, 55- and 42-kDa phosphopeptides) aremixtures of two 
components. However, the 32p-labelling of only one of 
these multiple components i  increased in response to 
hormonal challenge and subsequently decreased following 
~. 32  ~r ,  3 - transfer to medium free oi vu 4 , the 32 P-labelling of the 
other components of these mixtures being constant (results 
not shown; see Ref. [1 1]). The hormone-sensitive spots on 
two-dimensional electrophoresis correspond exactly to the 
phosphopeptides identified by others [4] as glycogen phos- 
phorylase, fructose 6-phosp]aate 2-kinase and fructose 1,6- 
bisphosphatase. Thus, we have chosen to use one-dimen- 
sional electrophoresis to resolve the phosphopeptides sim- 
ply because it resolves more phosphopeptides without 
compromising the capacity to quantitate the 32 P-labelling 
of specific phosphopeptides. 
4.2. Recovery from acute hormonal challenge is associated 
with asynchronous protein dephosphorvlation 
The dephosphorylation f the 11 glucagon-stimulated 
cytosolic phosphopeptides is asynchronous during the re- 
covery phase from acute glucagon challenge [11], implying 
that the process of protein dephosphorylation n intact cells 
may be complex and be a potential site for endocrine and 
nutritional modulation. This paper indicates that protein 
dephosphorylation s also asynchronous during the recov- 
ery phase from acute challenge with noradrenaline, vaso- 
pressin or angiotensin II. Statistical analysis confirms that 
on the basis of net rates of dephosphorylation three groups 
of cytosolic phosphopeptides can be delineated, consistent 
with post-hormonal protein dephosphorylation following 
the complex temporal patterns hown in Fig. 6. Glycogen 
phosphorylase is the most rapidly dephosphorylated phos- 
phopeptide, regardless of whether phosphorylation is stim- 
ulated with glucagon, noradrenaline, vasopressin or an- 
giotensin II. Despite stimulating the phosphorylation f the 
same subset of peptides, there are some differences in the 
temporal pattern of dephosphorylation reactions during the 
recovery phases from acute challenge with angiotensin II 
and vasopressin (Fig. 6), most notably in the rate of 
dephosphorylation of the 46-kDa phosphopeptide. 
One question that needs to be addressed is the extent o 
which loss of 32 P-labelling from a phosphopeptide is a true 
measure of its rate of dephosphorylation. Phosphate x- 
changes lowly in and out of the intact hepatocyte and, 
thus, there may be a delay before the intracellular ATP 
pool equilibrates with extracellular phosphate following 
removal of the extracellular 32po3-. During this time the 
rate of loss of 32p from the different phosphopeptides will 
depend not only on the rate of dephosphorylation but also 
on the rate of phosphorylaron. The rate of decline in the 
specific radioactivity of the.. [32p]ATP pool in the isolated 
hepatocytes following transfer to medium free of 32 PO43- 
is rapid (approx. 6.7% per min: [1 1]), suggesting that the 
capacity for 32 P-labelling is limited. Despite this, there is 
still some 3zp-labelling of the intracellular ATP pool as 
late as 10 min after transfer. Thus, there is the potential, 
albeit limited, for the 32 P-labelling of the peptides via the 
action of protein kinases following transfer. Thus, strictly 
speaking, the measured rates of decrease in the 32 P-label- 
ling of the phosphopeptides are a measure of net rates of 
dephosphorylation (i.e., the balance between the rates of 
dephosphorylation and phosphorylation), although dephos- 
phorylation is likely to be the predominant process. 
4.3. Physiological implications of asynchronous protein 
dephosphorylation 
One question that is posed by the asynchrony described 
(Fig. 6) and by the fact the pattern of dephosphorylation 
differs between the different hormones (viz. glucagon, 
noradrenaline, vasopressin, angiotensin II) relates to 
physiological importance. The results suggest that the de- 
phosphorylation and inactivation of glycogen phospho- 
rylase is an early event in the post-hormonal recovery 
process, regardless of the identity of the hormone that 
initially stimulates phosphorylation. The dephosphoryla- 
tion of this enzyme would be predicted to lead to the rapid 
inhibition of glycogenolysis. The dephosphorylation f 
most of the other phosphopeptides occurs after glycogen 
phosphorylase and would be predicted to be associated 
with the delayed inhibition of gluconeogenesis and, at least 
during recovery from glucagon or noradrenaline challenge, 
delayed activation of glycogen synthesis via the dephos- 
phorylation of glycogen synthase, Why the dephosphoryla- 
tion of certain phosphopeptides should be particularly slow 
remains obscure. Phenylalanine hydroxylase, for example, 
is dephosphorylated at a rate slower than most phospho- 
peptides, regardless of the identity of the hormone that 
initially stimulates phosphorylation. Dependent on the 
stimulating hormone, other phosphopeptides, including 
glycogen synthase, ribosomal protein $6 and the 46-kDa 
phosphopeptide, are also dephosphorylated at rates statisti- 
cally slower than most other phosphopeptides. The regula- 
tory implications of the asynchronous dephosphorylation 
of ribosomal protein $6, phenylalanine hydroxylase and 
the 48- and 46-kDa phosphopeptides r main obscure. The 
present study was modelled on other studies [4], and used 
lactate and pyruvate as substrates for the hepatocytes. Use 
of other substrates, particularly glucose, may influence the 
process of dephosphorylation and produce a different pat- 
tern of post-glucagon dephosphorylation of the individual 
phosphopeptides. 
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